Topic FDA

Products FDA

UHPLC-MS for high resolution applications

Is your current HPLC system limiting you? Do you want more sensitivity and confidence in your data than with UV detection? This offer is for you! more

Melamine Analysis in Pharmaceutical Industry with SeQuantTM ZIC®-HILIC columns from Merck

The FDA issued "Guidance for Pharmaceutical Industry" recommends using Merck's SeQuantTM ZIC®-HILIC HPLC for determination of melamine contamination in pharmaceutical raw materials more

News FDA

• Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella

  Agilent Technologies Inc. announced that it has entered into a Cooperative Research and Development Agreement with the U.S. Food and Drug Administration to develop new tools to detect and analyze pathogens in food. The joint R&D effort will also seek to improve DNA-based tools for confirming that se more

• FDA Approves Roche’s HPV Test for Identifying Women at Highest Risk for Cervical Cancer

  Roche announced that the US Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions about patient care, which may prevent many w more

• Epigenomics AG and NextPharma Sign Global Manufacturing Deal for Colorectal Cancer Blood Test

  Epigenomics AG and NextPharma Technologies announced that the companies have signed a global manufacturing contract for Epigenomics' Epi proColon product. Epi proColon, currently marketed in Europe, is the world's first in-vitro diagnostic test for the detection of colorectal cancer in a simple blo more

White papers FDA

• Predictor(TM) hERG Fluorescence Polarization Assay Kit performed on the PHERAstar/PHERAstar Plus
  

  The potential for cardiotoxic side-effects continues to challenge the development of small molecule based therapies. These intolerable side-effects are often precipitated by drug-induced long QT syndrome (LQT), which is often linked to blocking the human ether-a-go-go related gene (hERG) potassium channel. Although patch-clamp electrophysiology remains the gold standard for determining the interaction of compounds with the function of the hERG channel, radioligand displacement assays have proven to be a cost-effective initial alternative assay for hERG channel liability at early stages of compound development. more

• From Sephadex to GE Healthcare
  

  The success of chromatography as a technique for separating biomolecules is inevitably linked to the introduction of the gel filtration medium Sephadex(TM) by Pharmacia AB in 1959 more

Websites FDA